Literature DB >> 20812205

An LC-MS method for simultaneous determination of nine ginsenosides in rat plasma and its application in pharmacokinetic study.

Dandan Zhou1, Ling Tong, Meixu Wan, Gangli Wang, Zhengliang Ye, Zhengtao Wang, Ruichao Lin.   

Abstract

A sensitive and reliable LC-ESI-MS method for simultaneous determination of nine ginsenosides (Rh(1), Rg(2), Rg(1), Rf, Re, Rd, Rc, Rb(2) and Rb(1)) in rat plasma was developed and validated using saikosaponin A as an internal standard. The samples were extracted by solid-phase extraction. Chromatographic separation was carried out on a Hypersil Gold C(18) column (100 × 2.1 mm, 5 µm) by stepwise gradient elution with water (0.1% formic acid, v/v) and acetonitrile as the mobile phase. Detection was determined by selective ion monitoring mode using electrospray ionization in the negative ion mode. Good linearity over the investigated concentration ranges was observed with the values of r higher than 0.9900. The intra- and inter-day precisions were all no more than 15% and the average recoveries varied from 71.8 to 91.7%. This quantitative measurement was successfully applied to a pharmacokinetic study of Yi-Qi-Fu-Mai injection.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812205     DOI: 10.1002/bmc.1508

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

Review 1.  Ginsenoside Rb2: A review of pharmacokinetics and pharmacological effects.

Authors:  Longxing Miao; Yijun Yang; Zhongwen Li; Zengjun Fang; Yongqing Zhang; Chun-Chao Han
Journal:  J Ginseng Res       Date:  2021-11-19       Impact factor: 5.735

2.  Comparative pharmacokinetics of five saponins after intravenous administration of TSFS injection and TSFS injection plus TFFG in rats under different physiological states.

Authors:  Xiao-Ming Liu; Xing Zhao; En-Ze Gao; Yun-Li Zhao; Zheng Liu; Zhi-Guo Yu
Journal:  J Pharm Anal       Date:  2013-03-27

3.  Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation.

Authors:  Yongwei Nie; Yanxin Zhang; Zhi Li; Meixu Wan; Dekun Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.